The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate—a long-term follow-up comparison and quality of life analysis
Crossref DOI link: https://doi.org/10.1186/s40064-016-2280-8
Published Online: 2016-05-17
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dijkstra, Siebren
Witjes, Wim P. J.
Roos, Erik P. M.
Vijverberg, Peter L. M.
Geboers, Arno D. H.
Bruins, Jos L.
Smits, Geert A. H. J.
Vergunst, Henk
Mulders, Peter F. A.
License valid from 2016-05-17